1045P Safety and preliminary clinical activity of JNJ-78306358 (JNJ-358), an HLA-G and CD3 bispecific antibody, for the treatment of advanced stage solid tumor

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 34; pp. S633 - S634
Main Authors Geva, R., Vieito Villar, M., J. ramon, Perets, R., Pedregal, M., Corral de la Fuente, E., Doger de Spéville, B., Calvo, E., Bardina, J., Garralda, E., Brown, R.J., Gregor, J., Wu, S., Steinbach, D., Tsun-wen, S., Cao, Y., Lauring, J., Moreno Garcia, V.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2023
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2023.09.2184